The use of statins for cardiovascular disease prevention is clearly supported by clinical evidence. However, in January 2014 the U.S.
View Article and Find Full Text PDFThe use of statins for cardiovascular disease (CVD) prevention is clearly supported by clinical evidence. Although statin therapy is rather well tolerated, recent data from prospective and retrospective clinical trials and related meta-analyses suggest an increased incidence of new-onset type 2 diabetes mellitus (T2DM) in association with such treatment. The incidence of this adverse effect is not negligible, especially for specific subsets of patients, such as women, elderly, presence of familial history of T2DM and Asian ethnicity.
View Article and Find Full Text PDF